VANDA PHARMACEUTICALS INC. VNDA (NASDAQ)

(NEW YORK)Shares of Vanda Pharmaceuticals Inc. ticked higher Thursday after the company said it plans to send the Food and Drug Administration a response to the rejection of its experimental...READ MORE

Among the stock activity stories for Thursday, Sept. 11, from AP Financial News: NEW YORK (AP)--Shares of Titan International Inc. rose Thursday after the maker of off-road vehicle...READ MORE

(NEW YORK)Shares of Vanda Pharmaceuticals Inc. dove to a record low Monday after the Food and Drug Administration rejected the company's experimental schizophrenia treatment, prompting the d...READ MORE

Among the stock activity stories for Monday, July 28, from AP Financial News: NEW YORK (AP)_ Shares of Vanda Pharmaceuticals Inc. dove to their lowest point in more than two years ...READ MORE

(ROCKVILLE, Md.)Vanda Pharmaceuticals Inc. said Monday the Food and Drug Administration rejected the biotechnology company's experimental schizophrenia drug iloperidone, saying it was similar to d...READ MORE

(ROCKVILLE, Md.)While biotechnology company Vanda Pharmaceuticals Inc. said Thursday a late-stage trial for an insomnia drug met its goal, the drug failed to show a long-term benefit compared with...READ MORE

(NEW YORK)Shares of Vanda Pharmaceuticals surged Friday, a day after the drug developer reported a narrower-than-expected first-quarter loss and an analyst initiated coverage on the stock wi...READ MORE